Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news